Changchun, China

Xizhen Guangpu Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Changchun Institute of Biological Products, Ministry of Public Health. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xizhen Guangpu Zhang. Retrieved from https://idiyas.com/inventor/xizhen-guangpu-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xizhen Guangpu Zhang: Innovator in Hepatitis A Vaccine Development

Introduction

Xizhen Guangpu Zhang is a notable inventor based in Changchun, China. He has made significant contributions to the field of vaccine development, particularly in the area of hepatitis A. His innovative work has led to advancements that enhance the stability and storage of vaccines.

Latest Patents

Zhang holds a patent for a freeze-dried hepatitis A attenuated live vaccine and its stabilizer. This invention relates to a lyophilized attenuated hepatitis A vaccine that can be stored at ambient temperature for extended periods. The patent also includes a method for producing this vaccine, along with a stabilizer that improves the thermostability of the lyophilized live vaccine during processing and storage.

Career Highlights

Zhang is affiliated with the Changchun Institute of Biological Products, which operates under the Ministry of Public Health. His work at this institution has been pivotal in advancing public health through innovative vaccine solutions.

Collaborations

Zhang has collaborated with notable colleagues, including Ben Liang and Wei Wang. Their combined efforts have contributed to the success of various projects within the institute.

Conclusion

Xizhen Guangpu Zhang's contributions to vaccine development, particularly in hepatitis A, demonstrate his commitment to improving public health. His innovative approaches and collaborations continue to make a significant impact in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…